Page 226

and quality prescription drug services through its administrative 1 services model and the quantifiable cost and benefit of this service 2 delivery method. The authority must establish an annual reporting 3 requirement for all covered entities participating in the 340B drug 4 pricing program that receive medicaid funds under this section; and 5 the authority shall provide at an aggregate level, broken down by 6 covered entities defined by 42 U.S.C. §256b(a)(4)(A)-(O), the 7 following minimum information to the governor and fiscal committees 8 of the legislature no later than October 15, 2023: 9 (i) The cost and benefits of providing these prescription drug 10 benefits through a carved-out fee-for-service benefit, both total 11 cost and net of rebates; 12 (ii) The cost and benefits of providing these prescription drug 13 benefits through a carved-in managed care benefit, both total cost 14 and net of rebates; 15 (iii) The cost and benefits of providing these prescription drug 16 benefits through the administrative services model, both total and 17 net of rebates; 18 (iv) The community benefit attributable to 340B providers as a 19 result of the administrative services or carved-in model as compared 20 to each other and as compared to the carved-out model; and 21 (v) The federal financial participation provided to the state 22 under each of these models. 23 (c) The authority shall submit a report to the governor and 24 appropriate committees of the legislature by October 1, 2023, that 25 includes, but is not limited to: 26 (i) Specific, quantified actions that have been taken, to date, 27 related to the recommendations of the centers for medicare and 28 medicaid services center for program integrity as provided to the 29 authority in the January 2019 Washington focused program integrity 30 review final report; 31 (ii) Specific, quantified information regarding the work done 32 with its contracted actuary and the medical assistance expenditure 33 forecast expenditure work group to develop methods and metrics 34 related to managed care program integrity activity that shall be 35 incorporated into annual rate setting; 36 (iii) Specific, quantified information regarding the work done 37 with the medical assistance expenditure forecast work group to ensure 38 the results of program integrity activity are incorporated into the 39 p. 225 ESSB 5187.SL